Zileuton (Rising Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Zileuton drug offered from Rising Pharmaceuticals, Inc.. This 5-Lipoxygenase Inhibitor [EPC],5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Rising Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Zileuton
SUBSTANCE NAME: ZILEUTON
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: 5-Lipoxygenase Inhibitor [EPC],5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-03-21
END MARKETING DATE: 0000-00-00


Zileuton HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZileuton from Rising Pharmaceuticals, Inc.
LABELER NAME: Rising Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 600(mg/1)
START MARKETING DATE: 2017-03-21
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64980-206_225e95e7-cbe2-4721-9371-10a73bdd5978
PRODUCT NDC: 64980-206
APPLICATION NUMBER: ANDA204929

Other ZILEUTON Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Chiesi USA, Inc.ZYFLO
Prasco, LLCZileuton
Rising Pharmaceuticals, Inc.Zileuton